SKI Market

A+| A| A-|

Indian Indices

Sensex

76,503.60 -1,677.12
( -2.15%)

Global Indices

Nasdaq

52,927.94 -148.97
(-0.28%)

Dow Jones

7,522.05 -36.38
(-0.48%)

Hang Seng

67,213.51 -1,043.45
(-1.53%)

Nikkei 225

10,469.05 -196.83
(-1.85%)

Forex

USD-INR

95.36 0.17
(0.18%)

EUR-INR

108.98 0.13
(0.12%)

GBP-INR

127.38 0.36
(0.28%)

JPY-INR

0.59 0.00
(-0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

506197

INE416D01022

108.9247686

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BLISSGVS

55.3

5425.31

EPS(TTM)

Face Value()

Div & Yield %

9.25

0.1

Back

sylph technologies ltd

Board of Marksans Pharma recommends final dividend

May 26,2026

Marksans Pharma announced that the Board of Directors of the Company at its meeting held on 26 May 2026, inter alia, have recommended the final dividend of Rs 0.9 per equity Share (i.e. 90%) , subject to the approval of the shareholders.

76,503.60 -1,677.12 ( -2.15%)

52,927.94 -148.97 (-0.28%)

7,522.05 -36.38 (-0.48%)

67,213.51 -1,043.45 (-1.53%)

10,469.05 -196.83 (-1.85%)

95.36 0.17 (0.18%)

108.98 0.13 (0.12%)

127.38 0.36 (0.28%)

0.59 0.00 (-0.24%)